Bayer wins U.S. approval for Monsanto offer


By Patricia Weiss and Diane Bartz

FRANKFURT/WASHINGTON (Reuters) – Bayer (BAYGn.DE) won U.S. antitrust approval for its planned takeover of Monsanto (MON.N) on situation that it sells about $9 billion (6.8 billion kilos) in property, the Justice Section said on Tuesday, clearing a major hurdle for the $62.5 billion offer.

The divestiture necessary by U.S. antitrust enforcers “aligns closely” with divestitures the European Union needed, according to a resource experienced about the agreement between Bayer and the U.S. governing administration.

Makan Delrahim, who heads the Justice Department’s Antitrust Division, stated the asset profits agreed to by Bayer have been the “greatest at any time divestiture ever needed by the United States.”

In agreements with worldwide antitrust enforcers, Bayer fully commited to offer its full cotton, canola, soybean and vegetable seeds companies and electronic farming business, as nicely its Liberty herbicide, which competes with Monsanto’s Roundup.

Beneath agreements with European and other antitrust enforcers, Bayer has agreed to market belongings that contain its seed and some crop chemical compounds activities, with revenues of 2.2 billion euros (£1.9 billion), to rival BASF (BASFn.DE) for 7.6 billion euros.

Bayer claimed in a statement that it predicted Bayer and Monsanto to start out the integration method as before long as the gross sales to BASF are total, which it reported are envisioned to just take two months to total.

The German prescription drugs and everyday living sciences firm experienced mentioned it was on track to wrap up the offer before long. If it is not shut by June 14, Monsanto could withdraw from the takeover arrangement and seek a increased selling price.

Bayer has already secured the go-ahead from essential jurisdictions, together with the European Union, Brazil and Russia. Apart from the United States, it nonetheless requirements clearance in Canada and Mexico.

Bayer previous week reported synergies from folding Monsanto into its organisation would be about $300 million under its former target simply because it will have to sell more companies than to begin with anticipated.

“Receipt of the DOJ’s (Justice Department’s) acceptance provides us shut to our purpose of producing a foremost enterprise in agriculture,” Bayer CEO Werner Baumann explained in a assertion.

(Additional reporting by Ludwig Burger Editing by Mark Potter and Dan Grebler)



Bayer wins U.S. approval for Monsanto deal